Seeing Is Believing
Healthcare - Sector
KRYS is currently covered by 8 analysts with an average price target of $294.66. This is a potential upside of $45.75 (18.38%) from yesterday's end of day stock price of $248.91.
Krystal Biotech's activity chart (see below) currently has 119 price targets and 102 ratings on display. The stock rating distribution of KRYS is 85.19% BUY and 14.81% HOLD.
Analysts average stock forecasts to be materialized ratio is 94.22% with an average time for these price targets to be met of 291 days.
Highest price target for KRYS is $320, Lowest price target is $189, average price target is $250.5.
Most recent stock forecast was given by RITU BARAL from TD COWEN on 09-Jan-2026. First documented stock forecast 18-Oct-2017.
Currently out of the existing stock ratings of KRYS, 23 are a BUY (85.19%), 4 are a HOLD (14.81%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 29-Nov-2021
$306
$57.09 (22.94%)
$202
2 days ago
(09-Jan-2026)
5/6 (83.33%)
$57.09 (22.94%)
319
Buy
Since 24-Sep-2018
$310
$61.09 (24.54%)
$240
2 days ago
(09-Jan-2026)
36/37 (97.3%)
$61.09 (24.54%)
226
Buy
Since 09-Jan-2026
$320
$71.09 (28.56%)
$309
2 days ago
(09-Jan-2026)
6/8 (75%)
$71.09 (28.56%)
218
Buy
Since 29-Nov-2021
$220
$-28.91 (-11.61%)
$216
2 months 7 days ago
(04-Nov-2025)
15/15 (100%)
$22.15 (11.20%)
295
Buy
Since 18-Jan-2022
$255
$6.09 (2.45%)
$192
2 months 25 days ago
(17-Oct-2025)
3/4 (75%)
$64.77 (34.05%)
284
What is KRYS (Krystal Biotech) average time for price targets to be met?
Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?
Which analyst has the most public recommendations on KRYS (Krystal Biotech)?
Which analyst is the currently most bullish on KRYS (Krystal Biotech)?
Which analyst is the currently most reserved on KRYS (Krystal Biotech)?